Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of Y Chromosome Associates With Lung and Cardiac Dysfunction in COPD.

Comprehensive Physiology·2026
Same author

Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation.

The New England journal of medicine·2026
Same author

REPLY: Is There an Intramyocardial "Purkinje" System in the Heart?

JACC. Clinical electrophysiology·2025
Same author

Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial.

American heart journal·2025
Same author

Healthspan-lifespan gap differs in magnitude and disease contribution across world regions.

Communications medicine·2025
Same author

MYL4 Identifies Intramural Anatomy of Purkinje Fibers in Human Hearts.

JACC. Clinical electrophysiology·2025

Related Experiment Video

Updated: Apr 4, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.6K

Endpoints in stem cell trials in ischemic heart failure.

Marko Banovic1, Zlatibor Loncar2, Atta Behfar3

  • 1Cardiology Department, University Clinical Center of Serbia, Belgrade Medical School, 11000, Belgrade, Serbia. markobanovic71@gmail.com.

Stem Cell Research & Therapy
|August 31, 2015
PubMed
Summary

Regenerative therapies show promise for ischemic heart failure, but clinical trial evidence is limited. Careful trial design, including endpoint selection, is crucial for future success in stem cell therapy.

More Related Videos

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

11.0K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K

Related Experiment Videos

Last Updated: Apr 4, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.6K
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

11.0K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Advanced ischemic heart failure presents significant morbidity and mortality despite current treatments.
  • Regenerative therapies, particularly stem cell interventions, have emerged as a promising approach.
  • Clinical trials have established the feasibility and safety of stem cell-based treatments.

Purpose of the Study:

  • To review considerations for endpoint selection in regenerative clinical trials for ischemic heart failure.
  • To guide the translation of regenerative biotherapies into clinical benefit.
  • To address the limited efficacy data from current stem cell trials.

Main Methods:

  • Review of early randomized stem cell clinical trials in ischemic heart failure.
  • Analysis of key trial design elements including hypothesis, patient population, cell type, and delivery route.
  • Consideration of regulatory pathways and endpoint selection.

Main Results:

  • Stem cell trials have demonstrated clinical feasibility and safety in thousands of patients.
  • Evidence supporting the efficacy of stem cell interventions in ischemic heart failure remains limited.
  • Optimal trial design is critical for future regenerative therapy studies.

Conclusions:

  • Appropriate endpoint selection is paramount for the regulatory approval and clinical success of regenerative therapies.
  • Future trials must carefully consider trial design elements to effectively evaluate stem cell efficacy.
  • Translating the promise of regenerative medicine requires robust clinical trial strategies.